NRC
NRC HEALTH
-0.57 (-2.59%)21.48USD27.4K成交股數475M市值0.4本益比(近四季)3.4股價營收比+4.0%營收年增(近四季)2026-10-26下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 35.4M+4% | 34.8M+4% | 35.2M-2% | 34.6M-1% | 34.0M-4% | 33.6M-12% | 35.8M-6% | 35.0M-3% | 35.3M | 38.0M | 37.9M | 36.2M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 22.9M | 13.4M | 14.4M | 12.3M | 17.7M | 10.4M | 11.0M | 11.2M | 11.3M | 11.1M | 11.8M | 12.0M |
| 營業利益 | −3.2M-304% | 5.6M-35% | 4.7M-42% | 7.7M-13% | 1.6M-82% | 8.6M-27% | 8.0M-20% | 8.9M-5% | 8.8M | 11.7M | 10.0M | 9.4M |
| 營業利益率 | -9.1% | 16.0% | 13.3% | 22.4% | 4.7% | 25.6% | 22.3% | 25.3% | 24.8% | 30.8% | 26.2% | 25.9% |
| 稅後淨利 | −3.3M+2997% | 3.2M-44% | 1.8M-68% | 4.1M-33% | −106K-102% | 5.8M-35% | 5.7M-28% | 6.2M-15% | 6.4M | 8.9M | 7.9M | 7.3M |
| 淨利率 | -9.3% | 9.3% | 5.1% | 11.9% | -0.3% | 17.2% | 15.9% | 17.6% | 18.0% | 23.3% | 20.8% | 20.1% |
| 稀釋 EPS | -0.15+1400% | 0.14-44% | 49.58+20558% | 0.18-31% | -0.01-104% | 0.25-31% | 0.24-25% | 0.26-10% | 0.27 | 0.36 | 0.32 | 0.29 |
| 稀釋股數 | 22.0M | 21.9M | 22.4M | 22.1M | 22.7M | 23.0M | 23.7M | 23.9M | 24.0M | 24.7M | 24.7M | 24.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 3.3M | 2.5M | 4.1M | 2.2M | 5.3M | 2.5M | 3.5M | 485K | 1.7M | 6.7M | 3.8M | 22.5M |
| 應收帳款 | 9.3M | 10.8M | 11.1M | 12.7M | 12.4M | 11.3M | 11.1M | 10.1M | 11.1M | 12.4M | 14.5M | 11.9M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 136M | 135M | 135M | 136M | 141M | 135M | 132M | 119M | 121M | 122M | 120M | 134M |
| 有息負債 | 86.0M | 74.0M | 75.0M | 76.0M | 77.0M | 58.7M | 44.9M | 25.7M | 27.6M | 29.5M | 18.9M | 20.1M |
| 總負債 | 130M | 121M | 121M | 121M | 120M | 106M | 97.2M | 78.9M | 84.0M | 73.5M | 62.3M | 55.9M |
| 股東權益 | 6.5M | 13.5M | 14.0M | 14.3M | 21.3M | 29.7M | 34.6M | 40.2M | 36.9M | 49.0M | 57.9M | 77.8M |
| 負債比 | 95.2% | 90.0% | 89.6% | 89.5% | 84.9% | 78.0% | 73.7% | 66.2% | 69.4% | 60.0% | 51.8% | 41.8% |
| 淨現金(現金 − 有息負債) | −82.7M | −71.5M | −70.9M | −73.8M | −71.8M | −56.2M | −41.4M | −25.2M | −25.9M | −22.8M | −15.1M | 2.4M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 7.2M+8% | – | – | – | 6.6M | – | – | 12.0M | – | – | – |
| 資本支出 | – | 1.8M | – | – | – | 3.0M | – | – | 4.1M | – | – | – |
| 自由現金流 | – | 5.3M+46% | – | – | – | 3.7M | – | – | 7.9M | – | – | – |
| 折舊攤銷 | 2.1M | 2.2M | 2.1M | 2.2M | 1.7M | 1.5M | 1.5M | 1.5M | 1.4M | 1.4M | 1.6M | 1.5M |
| 買回庫藏股 | – | 1.9M | – | – | – | 4.9M | – | – | 15.0M | – | – | – |
| 現金股利 | – | 3.6M | – | – | – | 2.8M | – | – | 2.9M | – | – | – |
| 自由現金流率 | – | 15.4% | – | – | – | 10.9% | – | – | 22.4% | – | – | – |
營收拆解 2024 年度 10-K 的分部揭露 · 年增對前一年度
地區2024 年度 · 143M
| 美國 | 143M | 100.0% | -3.7% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 137M | -4.0% | 11.6M | 8.4% | 50.00 | 15.7M |
| FY2024 | 143M | -3.7% | 24.8M | 17.3% | 1.04 | 19.2M |
| FY2023 | 149M | -2.0% | 31.0M | 20.8% | 1.25 | 22.3M |
| FY2022 | 152M | +2.4% | 31.8M | 21.0% | 1.27 | 26.4M |
| FY2021 | 148M | +11.0% | 37.5M | 25.3% | 1.46 | 40.8M |
| FY2020 | 133M | +4.1% | 37.3M | 28.0% | 1.45 | 36.7M |
| FY2019 | 128M | +6.9% | 32.4M | 25.3% | 1.26 | 36.3M |
| FY2018 | 120M | – | 30.0M | 25.1% | – | 33.9M |